Literature DB >> 2252104

An immunohistochemical study of thymic epithelial tumors. III. The distribution of interdigitating reticulum cells and S-100 beta-positive small lymphocytes.

K Kondo1, K Mukai, Y Sato, Y Matsuno, Y Shimosato, Y Monden.   

Abstract

We report an immunohistochemical study of the distribution and number of interdigitating reticulum cells (IDC) and S-100 beta-positive small lymphocytes (S-100 beta + lymphocytes) in 53 thymomas and 11 thymic carcinomas. All 53 thymomas showed the presence of IDC in the tumor parenchyma. In most cases of predominantly lymphocytic and mixed-type thymoma, IDC clustered in areas, that corresponded to locations that had medullary differentiation and contained accumulated mature lymphocytes. By contrast, in most of the predominantly epithelial-type thymomas, IDC were scattered rather than forming clusters. The distribution and number of IDC were correlation with the histological type of thymoma but not with invasiveness. In thymic carcinomas, IDC were scattered in tumor nests. In 47 of the 53 thymomas (89%), infiltrating S-100 beta + lymphocytes were readily recognized. The remaining six cases without S-100 beta + lymphocytes were noninvasive thymoma. We conclude that the degree of S-100 beta + lymphocyte infiltration is correlated with the stage of thymoma and may be a marker of thymoma malignancy.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2252104

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  7 in total

1.  Thymoma: tumour type related to expression of epidermal growth factor (EGF), EGF-receptor, p53, v-erb B and ras p21.

Authors:  Y Hayashi; N Ishii; C Obayashi; K Jinnai; K Hanioka; Y Imai; H Itoh
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

2.  Fascin expression in dendritic cells and tumor epithelium in thymoma and thymic carcinoma.

Authors:  Junichiro Sato; Masachika Fujiwara; Tomohiro Kawakami; Ayumi Sumiishi; Seiji Sakata; Atsuhiko Sakamoto; Atsushi Kurata
Journal:  Oncol Lett       Date:  2011-08-17       Impact factor: 2.967

3.  High frequency of p53 protein expression in thymic carcinoma but not in thymoma.

Authors:  N Hino; K Kondo; T Miyoshi; T Uyama; Y Monden
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

4.  Immunohistochemical localization of CD1a-positive putative dendritic cells in human breast tumours.

Authors:  E E Hillenbrand; A M Neville; B J Coventry
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

5.  The activation status of neuroantigen-specific T cells in the target organ determines the clinical outcome of autoimmune encephalomyelitis.

Authors:  Naoto Kawakami; Silke Lassmann; Zhaoxia Li; Francesca Odoardi; Thomas Ritter; Tjalf Ziemssen; Wolfgang E F Klinkert; Joachim W Ellwart; Monika Bradl; Kimberly Krivacic; Hans Lassmann; Richard M Ransohoff; Hans-Dieter Volk; Hartmut Wekerle; Christopher Linington; Alexander Flügel
Journal:  J Exp Med       Date:  2004-01-19       Impact factor: 14.307

6.  Difference in distribution profiles between CD163+ tumor-associated macrophages and S100+ dendritic cells in thymic epithelial tumors.

Authors:  Mutsuko Omatsu; Toshiaki Kunimura; Tetsuya Mikogami; Akira Shiokawa; Tomoko Nagai; Atsuko Masunaga; Akihiko Kitami; Takashi Suzuki; Mitsutaka Kadokura
Journal:  Diagn Pathol       Date:  2014-12-14       Impact factor: 2.644

7.  Expression of RAGE and HMGB1 in thymic epithelial tumors, thymic hyperplasia and regular thymic morphology.

Authors:  Bernhard Moser; Stefan Janik; Ana-Iris Schiefer; Leonhard Müllauer; Christine Bekos; Anke Scharrer; Michael Mildner; Ferenc Rényi-Vámos; Walter Klepetko; Hendrik Jan Ankersmit
Journal:  PLoS One       Date:  2014-04-04       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.